HK inno.N Corporation: all 99 studies

Page 1 of 1. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male VolunteersNot yet recruitingNCT07853248Phase 1
• A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERDNot yet recruitingNCT07826455Phase 4
• An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD PatientsRecruitingNCT07678177
• A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With SarcopeniaNot yet recruitingNCT07668180Phase 2
• A Study to Evaluate the Pharmacokinetics and Safety of IN-M00007 and IN-R00007 in Healthy Adult VolunteersNot yet recruitingNCT07311811Phase 1
• Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise AloneNot yet recruitingNCT07308184Phase 3
• A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult VolunteersNot yet recruitingNCT07277712Phase 1
• Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes MellitusNot yet recruitingNCT07192263Phase 3
• A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult PatientsRecruitingNCT07073677Phase 2
• This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy ParticipantsNot yet recruitingNCT06736912Phase 1
• Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer PatientsRecruitingNCT06389552
• PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy SubjectsEnrolling by invitationNCT06332638Phase 1
• Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy SubjectsNot yet recruitingNCT06164834Phase 1
• Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive PatientsRecruitingNCT05933031Phase 2
• A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime HeartburnRecruitingNCT05701540Phase 4
• To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult VolunteersActive, not recruitingNCT06725355Phase 1
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis PatientsCompletedNCT05729074Phase 1
• PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy VolunteersCompletedNCT05723510Phase 1
• A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy VolunteersStatus unknownNCT05353010Phase 1
• Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301CompletedNCT05337228Phase 3
• Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301CompletedNCT05299099Phase 3
• Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux DiseaseCompletedNCT05267743Phase 4
• A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult VolunteersStatus unknownNCT05223101Phase 1
• Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)Status unknownNCT05113849Phase 1
• A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult VolunteersCompletedNCT05040880Phase 1
• A Study to Investigate the Effect of Food on the Pharmacokinetics of IN-A002 Capsule in Healthy Male SubjectsStatus unknownNCT05019755Phase 1
• Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy CaucasiansCompletedNCT05005065Phase 1
• Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDsCompletedNCT04840550Phase 3
• Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy VolunteersCompletedNCT04654078Phase 1
• Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy VolunteersCompletedNCT04654065Phase 1
• Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male VolunteersCompletedNCT04639804Phase 1
• Safety and Immunogenicity of High-dose IN-B001 in Healthy SubjectsStatus unknownNCT04637919Phase 1
• A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy SubjectsStatus unknownNCT04587011Phase 1
• A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy ControlsStatus unknownNCT04494269Phase 1
• Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean SubjectsCompletedNCT04486157Phase 1
• A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male SubjectsStatus unknownNCT04485884Phase 1
• Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep DisturbanceCompletedNCT04309916Phase 4
• Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male SubjectsStatus unknownNCT04297865Phase 1
• Study to Evaluate the Pharmacodynamics After Single Oral Dosing of Tegoprazan, EAPA115 and RAPA115 in Healthy VolunteersCompletedNCT04231136Phase 1
• Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult VolunteersCompletedNCT04221321Phase 1
• Safety and Immunogenicity of CJ-40010 in Healthy SubjectsStatus unknownNCT04182932Phase 1
• Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male VolunteersCompletedNCT04171687Phase 1
• Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOTCompletedNCT04128917Phase 3
• Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy VolunteersCompletedNCT04066257Phase 1
• Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive EsophagitisCompletedNCT04022096Phase 3
• Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male SubjectsCompletedNCT03863938Phase 1
• Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination TabletsCompletedNCT03847506Phase 4
• Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male ParticipantsCompletedNCT03814642Phase 1
• Bioequivalence Study of CJ-30060 in Healthy VolunteersStatus unknownNCT03757390Phase 1
• Bioequivalence Study of CJ-30061 in Healthy Male VolunteersCompletedNCT03657472Phase 1
• Bioequivalence Study of CJ-30060 in Healthy Male VolunteersCompletedNCT03639493Phase 1
• Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With HyperlipidemiaStatus unknownNCT03639480Phase 3
• Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male VolunteersCompletedNCT03542916Phase 1
• Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With HyperlipidemiaCompletedNCT03536598Phase 3
• A Phase 1 Study of Tegoprazan on Healthy Male VolunteersStatus unknownNCT03530228Phase 1
• Triple Therapy With Tegoprazan in H. Pylori Positive PatientsCompletedNCT03498456Phase 3
• A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male VolunteersCompletedNCT03378284Phase 1
• A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive PatientsCompletedNCT03317223Phase 3
• Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and CandesartanStatus unknownNCT03231982Phase 4
• Pharmacodynamic Properties of CJ-12420 on Evening DosingCompletedNCT03043521Phase 1
• To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose AdministrationCompletedNCT03011996Phase 1
• To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose AdministrationCompletedNCT03009760Phase 1
• Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male VolunteersCompletedNCT03009474Phase 1
• Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT03006874Phase 3
• A Study to Compare the Pharmacokinetic Characteristics of CJ-12420CompletedNCT02995239Phase 1
• Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric UlcerCompletedNCT02761512Phase 3
• Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux DiseaseCompletedNCT02556021Phase 3
• Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT02456935Phase 3
• Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mgCompletedNCT02378441Phase 1
• A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate MonotherapyCompletedNCT02368665Phase 3
• A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCompletedNCT02368652Phase 3
• Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XRCompletedNCT02185066Phase 1
• Bioequivalence Study of CJ-30059Status unknownNCT02173912Phase 1
• The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male SubjectsCompletedNCT02160743Phase 1
• Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male SubjectsCompletedNCT02146625Phase 1
• Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With SchizophreniaCompletedNCT02137993Phase 4
• Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male SubjectsCompletedNCT02069821Phase 1
• Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male SubjectsCompletedNCT02060019Phase 1
• A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionStatus unknownNCT02059616Phase 2
• Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male SubjectsCompletedNCT02052336Phase 1
• Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive EsophagitisCompletedNCT02028663Phase 2
• to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male VolunteersCompletedNCT01926548Phase 1
• A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male VolunteersCompletedNCT01925313Phase 1
• Pharmacokinetic Interactions of Bisoprolol and RosuvastatinWithdrawnNCT01925300Phase 1
• Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine BesylateStatus unknownNCT01845272Phase 1
• Food-Effect on PK and PD of Single Oral Dose of CJ-12420 in Healthy Male SubjectsCompletedNCT01830309Phase 1
• Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and ClosoneCompletedNCT01765452Phase 4
• Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male SubjectsCompletedNCT01765023Phase 1
• Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg TabletCompletedNCT01735890Phase 1
• To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil SupraCompletedNCT01501435Phase 1
• Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mgCompletedNCT01494727Phase 1
• Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male SubjectsCompletedNCT01489774Phase 1
• Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male SubjectsCompletedNCT01473173Phase 1
• A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy SubjectCompletedNCT01380873Phase 1
• A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus PatientsCompletedNCT01370707Phase 3
• A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy SubjectCompletedNCT01370681Phase 1
• Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination TherapyStatus unknownNCT01062139Phase 4
• A Drug Interaction Study of SLM0807 and HKB0701 in Healthy SubjectsCompletedNCT01039896Phase 1
• Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and CirrhosisCompletedNCT00956098Phase 2

← HK inno.N Corporation overview and focus areas